Lynozyfic
RxNorm concept 2719485, brand name (bn).
- RxCUI
- 2719485
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2719485 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- linvoseltamab-gcpt (PIN, has precise ingredient)
- linvoseltamab-gcpt 20 MG/ML [Lynozyfic] (SBDC, ingredient of)
- Lynozyfic Injectable Product (SBDG, ingredient of)
- linvoseltamab Injection [Lynozyfic] (SBDF, ingredient of)
- 10 ML linvoseltamab-gcpt 20 MG/ML Injection [Lynozyfic] (SBD, ingredient of)
- linvoseltamab-gcpt 2 MG/ML [Lynozyfic] (SBDC, ingredient of)
- 2.5 ML linvoseltamab-gcpt 2 MG/ML Injection [Lynozyfic] (SBD, ingredient of)
- linvoseltamab (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2719485 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2719485 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2719485. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.